Laura H. Mufson, PhD, is a Professor of Medical Psychology (in Psychiatry) at Columbia University Medical Center (CUMC), co-director of the Office of Clinical Psychology at CUMC, and director of the Department of Clinical Psychology at New York State Psychiatric Institute (NYSPI). In addition, she is director of Clinical Child Psychology in Child Psychiatry and director of training for the Child Track of the APA–Accredited Predoctoral Internship in Clinical Psychology. She also is a consulting research psychologist on the Children’s Day Unit and a faculty member of the Division of Child Psychiatry’s NIMH T32 Postdoctoral Research Fellowship.
Dr. Mufson is the developer of the adolescent adaptation of interpersonal psychotherapy for depression (IPT-A) and is the leading expert on its use with depressed adolescents. She is also co-author of the prevention model (IPT-AST) and the model for prepubertal depression (FB-IPT). Dr. Mufson has authored numerous publications on adolescent depression, temperament, psychopathology, and risk factors for psychopathology; as well as articles and book chapters on the treatment of adolescent depression and interpersonal psychotherapy. Dr. Mufson conducts training workshops on IPT-A throughout the United States, UK, Europe, and Scandinavia.
Dr. Mufson's primary research interest is in the evaluation of empirically supported psychotherapy outcomes both in the efficacy and effectiveness arenas and the identification of which treatments work best for whom. She is a principal investigator, co-investigator, and/or consultant with colleagues on numerous grants studying adaptations of IPT-A to be delivered in schools, primary care clinics, and community clinics serving minority populations, as well as models for prevention of depression, anxiety, and peer victimization, and for the treatment of prepubertal depression. Her areas of expertise include the evaluation of empirically supported intervention outcomes in clinical trials conducted in research and community settings, transportability and dissemination of treatments into the community, and models for training clinicians in empirically supported psychotherapies. In addition, her studies have looked at mediators and moderators of treatment response, including stress response measured by salivary cortisol levels, levels of interpersonal conflict, and comorbid disorders.